582.35
+2.39%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Metropolis Healthcare
Its shares trade on NSE under the ticker METROPOLIS.NS. It has been listed since 15 April 2019. In the fiscal year to 31 March 2026, it reported revenue of ₹16.46bn and net income of ₹1.90bn. At that date it held total assets of ₹21.38bn and shareholders' equity of ₹15.13bn.
Metropolis Healthcare Ltd. owns and operates medical laboratories. The company is headquartered in Gurgaon, Haryana. The company went IPO on 2019-04-15. The firm offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The firm also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The firm offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The firm has spread its footprint across 20 Indian states and over 210 cities.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 15 Apr 2019
- Employees
- 4,532
- Website
- metropolisindia.com ↗
Leadership
Pay as last reported
- Ms. Ameera ShahExecutive Chairman of the Board, since 2024₹58.9m
- Mr. Surendran ChemmenkottilChief Executive Officer₹23.3m
- Mr. Sameer PatelChief Financial Officer
- Dr. Nilesh ShahPresident Internal Assurance and Advisor to Chief Executive Officer, since 2024
- Ms. Diya SuriChief People Officer
- Mr. Pinakin ShahChief Information Officer
- Mr. Mohan MenonChief Marketing Officer
- Dr. Kirti ChadhaChief Scientific Officer, Innovation Officer and Group Head CSR, since 2024
- Mr. Kamlesh KulkarniCompliance Officer, Company Secretary, Head - Legal and Secretarial
- Mr. Kannan AlangadanChief Business Officer - South India, since 2025
- Mr. Avadhut JoshiChief Business Development Officer
- Mr. Umesh RaiHead - Emerging Business
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 90
- Environment
- 98
- Social
- 97
- Governance
- 75
- Direct emissions (scope 1)
- 132.12 t
- Energy emissions (scope 2)
- 9,267.939 t
- Value chain emissions (scope 3)
- 2,387.152 t
- Women in the workforce
- 45%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Metropolis Healthcare Ltd possesses several strengths that provide it with a competitive edge:
Weaknesses
- Despite its strengths, Metropolis Healthcare Ltd also faces certain weaknesses that need to be addressed:
Opportunities
- Metropolis Healthcare Ltd operates in an industry that presents several opportunities for growth and development:
Threats
- Metropolis Healthcare Ltd operates in a dynamic environment that exposes it to certain threats:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.